|
1
|
Jeon BC, Park YS, Oh HS, Kim YS and Chun
BK: Pituitary apoplexy complicated by chemical meningitis and
cerebral infarction. J Korean Med Sci. 22:1085–1089. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dev R, Singh SK, Sharma MC, Khetan P and
Chugh A: Post traumatic pituitary apoplexy with contiguous intra
cerebral hematoma operated through endonasal route-a case report.
Pituitary. 10:291–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ben-Nakhi A, Muttikkal TJ, Chavan VN,
Al-Turkomani AY and Gupta R: Pituitary apoplexy: A rare cause of
cerebral infarction. A case report. Neuroradiol J. 21:661–665.
2008.
|
|
4
|
Ahmed SK and Semple PL: Cerebral ischaemia
in pituitary apoplexy. Acta Neurochir (Wien). 150:1193–1196. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cerase A, Tarantino A, Muzii VF, Vittori C
and Venturi C: Vasospasm and cerebral infarction from pituitary
apoplexy. A case report. Neuroradiol J. 23:321–324. 2010.
|
|
6
|
López Hernández N, García Escrivá A, Moltó
Jordá JM and García Barragán N: Massive cerebral infarction
secondary to apoplexy due to pituitary adenoma. Neurologia.
23:248–255. 2008.(In Spanish). PubMed/NCBI
|
|
7
|
Das NK, Behari S and Banerji D: Pituitary
apoplexy associated with acute cerebral infarct. J Clin Neurosci.
15:1418–1420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang C, Feng F, Zhu Y, Wang R and Xing B:
Cerebral infarction caused by pituitary apoplexy: Case report and
review of literature. Turk Neurosurg. 24:782–787. 2014.PubMed/NCBI
|
|
9
|
de Silva DA, Woon FP, Gan HY, Cameron J,
Kingwell B, Koh TH, Chen C, Chang HM and Wong MC: Arterial
stiffness, metabolic syndrome and inflammation amongst Asian
ischaemic stroke patients. Eur J Neurol. 15:872–875. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chamorro A and Planas AM:
Inflammation-mediated damage as a potential therapeutic target in
acute ischemic stroke. Ernst Schering Res Found Workshop. pp.
185–204. 2004, PubMed/NCBI
|
|
11
|
Chamorro A: Role of inflammation in stroke
and atherothrombosis. Cerebrovasc Dis. 17(Suppl 3): S1–S5. 2004.
View Article : Google Scholar
|
|
12
|
Zhang W and Stanimirovic D: Current and
future therapeutic strategies to target inflammation in stroke.
Curr Drug Targets Inflamm Allergy. 1:151–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McColl BW, Allan SM and Rothwell NJ:
Systemic infection, inflammation and acute ischemic stroke.
Neuroscience. 158:1049–1061. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Filipova J, Rihova L, Vsianska P, Kufova
Z, Kryukova E, Kryukov F and Hajek R: Flow cytometry in
immunoglobulin light chain amyloidosis: Short review. Leuk Res, Jul
13, 2015 (Epub ahead of print).
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaplan RC, McGinn AP, Baird AE, Hendrix
SL, Kooperberg C, Lynch J, Rosenbaum DM, Johnson KC, Strickler HD
and Wassertheil-Smoller S: Inflammation and hemostasis biomarkers
for predicting stroke in postmenopausal women: The women's health
initiative observational study. J Stroke Cerebrovasc Dis.
17:344–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McColl BW, Rothwell NJ and Allan SM:
Systemic inflammation alters the kinetics of cerebrovascular tight
junction disruption after experimental stroke in mice. J Neurosci.
28:9451–9462. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Theodorou GL, Marousi S, Ellul J, Mougiou
A, Theodori E, Mouzaki A and Karakantza M: T helper 1 (Th1)/Th2
cytokine expression shift of peripheral blood CD4+ and CD8+ T cells
in patients at the post-acute phase of stroke. Clin Exp Immunol.
152:456–463. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Caso JR, Pradillo JM, Hurtado O, Lorenzo
P, Moro MA and Lizasoain I: Toll-like receptor 4 is involved in
brain damage and inflammation after experimental stroke.
Circulation. 115:1599–1608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lip GY, Patel JV, Hughes E and Hart RG:
High-sensitivity C-reactive protein and soluble CD40 ligand as
indices of inflammation and platelet activation in 880 patients
with nonvalvular atrial fibrillation: Relationship to stroke risk
factors, stroke risk stratification schema, and prognosis. Stroke.
38:1229–1237. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Castillo J, Alvarez-Sabin J, Martinez-Vila
E, Montaner J, Sobrino T and Vivancos J; MITICO Study
Investigators: Inflammation markers and prediction of post-stroke
vascular disease recurrence: The MITICO study. J Neurol.
256:217–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nguyen H, Aum D, Mashkouri S, Rao G, Vega
Gonzales-Portillo JD, Reyes S and Borlongan CV: Growth factor
therapy sequesters inflammation in affording neuroprotection in
cerebrovascular diseases. Expert Rev Neurother. 16:915–926. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tong Y, Han J, Guan X, Lu Z, Miao X, Ye J,
Hou SY, Zhang Y, Geng Y, Li Y, et al: Association of IL-1 receptor
antagonist gene VNTR polymorphism with ischemic stroke in the
Chinese Uyghur population. Biochem Genet. 51:698–706. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sumbria RK, Boado RJ and Pardridge WM:
Brain protection from stroke with intravenous TNFα decoy
receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab.
32:1933–1938. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Al-Bahrani A, Taha S, Shaath H and Bakhiet
M: TNF-alpha and IL-8 in acute stroke and the modulation of these
cytokines by antiplatelet agents. Curr Neurovasc Res. 4:31–37.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma S, Zhong D, Chen H, Zheng Y, Sun Y, Luo
J, Li H, Li G and Yin Y: The immunomodulatory effect of bone marrow
stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated
ischemic stroke in mice. J Neuroimmunol. 257:28–35. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kwan J, Horsfield G, Bryant T, Gawne-Cain
M, Durward G, Byrne CD and Englyst NA: IL-6 is a predictive
biomarker for stroke associated infection and future mortality in
the elderly after an ischemic stroke. Exp Gerontol. 48:960–965.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fouda AY, Kozak A, Alhusban A, Switzer JA
and Fagan SC: Anti-inflammatory IL-10 is upregulated in both
hemispheres after experimental ischemic stroke: Hypertension blunts
the response. Exp Transl Stroke Med. 5:122013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sieber MW, Jaenisch N, Brehm M, Guenther
M, Linnartz-Gerlach B, Neumann H, Witte OW and Frahm C: Attenuated
inflammatory response in triggering receptor expressed on myeloid
cells 2 (TREM2) knock-out mice following stroke. PLoS One.
8:e529822013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin R, Yang G and Li G: Inflammatory
mechanisms in ischemic stroke: Role of inflammatory cells. J Leukoc
Biol. 87:779–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
